Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock.
@article{Allegra1996AdministrationOR, title={Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock.}, author={Alessandro Allegra and Anastasia Galasso and Licia Vanessa Siracusano and Calmela Aloisi and Francesco Corica and Angela Lagan{\`a} and Nicola Frisina and Michele Buemi}, journal={Nephron}, year={1996}, volume={74 2}, pages={ 431-2 } }
Administration of Recombinant Erythropoietin Determines Increase of Peripheral Resistances in Patients with Hypovolemic Shock A. Alessandro Allegra A. Anselmo Galasso L. Luca Siracusano C. Carmela Aloisi F. Francesco Corica A. Angela Laganà N. Nicola Frisina M. Michele Buemi Internal Medicine Department, Messina University, Medical Pathology I, Anesthesia and Resuscitation Department, Catanzaro Hospital, Anesthesia and Resuscitation Department, Polyclinic, Messina, Italy
Tables from this paper
12 Citations
Pulmonary Hypertension and Erythropoietin
- Medicine, BiologyKidney and Blood Pressure Research
- 2007
The effects of recombinant human erythropoietin, a drug widely used in patients on dialysis, on the pulmonary circulation were studied to maintain or induce a reduction in pulmonary arterial pressure.
Management of Renal Anemia in Children with Chronic Kidney Disease
- Medicine, Biology
- 2012
The mechanism of action of hepcidin, a new iron-regulating molecule produced by the liver, provides a better understanding of why dialysis patients do not absorb oral iron well, and there is great interest in exploring how new ESAs, and particularly the prolyl hydroxylase inhibitors, impact hePCidin levels.
Hemodynamic Effects of Recombinant Human Erythropoietin
- Biology, MedicineNephron
- 1999
The presence of vascular receptors whose activation induces vasoconstriction, suggests that three renal systems, i.e. erythropoietin, the renin angiotensin-aldosterone system, and the antiFig.
Erythropoietin does not have effects on the ventilatory and pulmonary vascular response to acute hypoxia in men and women
- Medicine, BiologyExperimental physiology
- 2016
Erythropoeitin does not influence the ventilatory and pulmonary vascular responses to acute hypoxia in men or women.
Bench to bedside: A role for erythropoietin in sepsis
- Medicine, BiologyCritical care
- 2010
Good quality data exist from studies on anaemia in critically ill patients, giving useful information of its pharmacokinetics and potential for harm, and the evidence would support further phase II and III clinical trials examining this molecule as an adjunctive treatment in sepsis.
La eritropoyetina: de la eritropoyesis a la cardioprotección Erythropoietin: from erythropoiesis to cardioprotection
- Medicine, Biology
- 2010
Clinical data are limited and does not suggest that the use of these agents promotes the survival of patients undergoing cardiotoxic treatments, but the hypothesis that erythropoietin may be able to prevent heart damage is supported.
La eritropoyetina: de la eritropoyesis a la cardioprotección
- Medicine, Biology
- 2010
The hypothesis that erythropoietin may be able to prevent anthracycline-induced cardiomyopathy is addressed, and clinical data are limited and does not suggest that the use of these agents promotes the survival of patients undergoing cardiotoxic treatments.
Possible role of erythropoietin in the pathogenesis of chronic cor pulmonale
- Medicine, Biology
- 2005
The patient con-tinues on long-term voraconazole and is currently well with acreatinine of 138mmol/l, at 24 months post-renal transplant.
Elenco Parziale Prodotti di Ateneo
- Chemistry
- 2006
CORSONELLO A; PEDONE C; LATTANZIO F; LUCCHETTI M; GARASTO S; DI MUZIO M; GIUNTA S; ONDER G; DI IORIO A; VOLPATO S; F. CORICA; MUSSI C; AND ANTONELLI INCALZI R; ON BEHALF OF THE PHARMACOSURVEILLANCE…
Possible role of erythropoietin in the pathogenesis of chronic cor pulmonale.
- MedicineNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
- 2005
References
SHOWING 1-10 OF 12 REFERENCES
Recombinant human erythropoietin inhibits the cutaneous vasodilatation induced by acetylcholine.
- Medicine, BiologyInternational journal of microcirculation, clinical and experimental
- 1995
The data suggest that rHuEPO exerts an indirect vasoconstrictive effect and that acetylcholine-induced vasodilatation, which is endothelium-dependent, is blunted by the vasoconStrictive activity of r HuEPO, thus demonstrating that the hormone may impair the synthesis of endothelial nitric oxide.
Cachectin: a hormone that triggers acute shock and chronic cachexia.
- Medicine, BiologyThe Journal of infectious diseases
- 1988
Septic shock and invasive infection are diseases caused by humoral mediators of both exogenous and endogenous origin. The search for and identification of these factors has led to the discovery and…
Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.
- Biology, MedicineThe Journal of clinical investigation
- 1992
Results showing increased endogenous nitrate synthesis in patients receiving IL-2 demonstrate for the first time that a cytokine-inducible, high-output L-arginine/NO pathway exists in humans.
Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.
- Biology, MedicineJournal of the National Cancer Institute
- 1990
It is suggested that endothelial cell-derived nitric oxide plays a role in the development of hypotension in patients treated with tumor necrosis factor or interleukins and that administration of substrate analogues such as L-NMMA may favorably alter the toxicity associated with these immunomodulators and result in a higher maximum tolerated dose, with subsequent improvement in the antitumor activity.
Inhibition of Interleukin-1-α-Induced Nitric Oxide Synthase in Vascular Smooth Muscle and Full Reversal of Interleukin-1-α-Induced Hypotension by Nω-Amino-L-arginine
- Biology, Medicine
- 1992
Investigation of the role of nitric oxide (NO.) as a possible mediator of hypotension in IL-1-activated rat aortic smooth muscle cells indicates that vascular smooth muscle is a likely source as well as a target of IL- 1-induced NO, and administration of inhibitors of Nitric oxide synthase inhibitors can fully reverse this hypotension.
Endothelin stimulates c‐fos and c‐myc expression and proliferation of vascular smooth muscle cells
- Biology, MedicineFEBS letters
- 1988
Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism.
- Biology, MedicineImmunopharmacology
- 1982
Antihypertensive Effect of Interleukin‐2
- Biology, MedicineHypertension
- 1990
A single bolus of interleukin-2 prevented the increase of blood pressure in the young spontaneously hypertensive rat (SHR) and lowered pressure to normotensive levels in the well-established hypertensive adult SHR.
Eritropoietina ricombinante ed ipertensione arteriosa
- Ital Nefrol
- 1990